Raltegravir: first in class HIV integrase inhibitor.

Therapeutics and Clinical Risk Management
Zelalem Temesgen, Dawd S Siraj

Abstract

On October 16, 2007, the US Food and Drug Administration (FDA) approved raltegravir for treatment of human immunodeficiency virus (HIV)-1 infection in combination with other antiretroviral agents in treatment-experienced adult patients who have evidence of viral replication and HIV-1 strains resistant to multiple antiretroviral agents. Raltegravir is first in a novel class of antiretroviral drugs known as integrase inhibitors. It has demonstrated potent anti HIV activity in both antiretroviral treatment-naïve and experienced patients. The most common adverse events reported with raltegravir during phase 2 and 3 clinical trials were diarrhea, nausea, and headache. Laboratory abnormalities include mild elevations in liver transaminases and creatine phosphokinase.

Citations

May 15, 2013·Expert Opinion on Therapeutic Patents·Afshin Zarghi, Zahra Hajimahdi
Dec 6, 2017·Pharmacogenomics·Jessica CusatoAntonio D'Avolio
Sep 3, 2020·The AAPS Journal·Sana-Kay Whyte-Allman, Reina Bendayan
Aug 6, 2015·Drugs·Walter DehorityRolando M Viani
Nov 11, 2016·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Luisa FiandraFabio Corsi
Jun 6, 2018·PloS One·Cristina TintoriMaurizio Botta
Aug 29, 2012·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Cledualdo Soares de OliveiraPetrônio Filgueiras de Athayde-Filho
Jan 24, 2014·Acta Crystallographica. Section E, Structure Reports Online·Thammarse S YamunaManpreet Kaur
Jan 19, 2013·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Tony AntoniouCharles La Porte
Jan 8, 2021·Chemical Reviews·Ashley N MatthewCelia A Schiffer
Apr 8, 2021·Emerging Topics in Life Sciences·Shubhankar Dutta, Kakoli Bose
Apr 15, 2021·International Journal of Antimicrobial Agents·Nokuzola MbheleMichelle Gordon
Jun 3, 2021·Cells·Athanasios-Dimitrios Bakasis, Theodoros Androutsakos
Jul 22, 2021·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Engie SalamaJeremiah D Momper

❮ Previous
Next ❯

Software Mentioned

Isentress
BENCHMRK

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved